Publication | Open Access
Phase I dose escalation study of MK-0457, a novel Aurora kinase inhibitor, in adult patients with advanced solid tumors
86
Citations
26
References
2010
Year
OncologyMedicineAdult PatientsAdvanced Solid TumorsImmune Checkpoint InhibitorAnti-cancer AgentCancer TreatmentPharmacologyCell BiologyEscalation Study
| Year | Citations | |
|---|---|---|
Page 1
Page 1